sequ-, sequi-, secut-, suit-, -sue
(Latin: follow, followed, following)
2. To institute proceedings against (a person or organization) for reparations for being wronged or injured.
3. Etymology: "continue, persevere", from Anglo-French suer, "follow after, continue"; from Old French sivre, later suivre, "pursue, follow after"; from Vulgar Latin sequere, "to follow"; from Latin sequi, "follow".
Greta's dress was a suitable choice for her friend's wedding ceremony.
2. Pertaining to what is right for a particular purpose, person, or situation: Latisha found that the parking lot was full, and the nearest alternate and suitable parking area was three blocks farther away.
Vince's experiences make him more suitable for the new job.
Meagan was warned that the movie her children wanted to see was not suitable for them.
Jane went out to work in the garden in her high-heeled shoes, but she certainly wasn't suitably clothed for pulling weeds!
2. Pertaining to how a person or something is fitting or apt; fittingly; aptly: Mary decided to make a dramatic entrance to the party to make sure that everyone was suitably impressed.
2. A group of related things intended to be used together; for example, a set of matched furniture: "Loyd and Lesley bought a new dining room suite for their apartment."
3. A series of connected rooms used as a living unit: "The couple rented the bridal suite for their wedding."
4. An instrumental composition, especially of the 17th or 18th century, consisting of a succession of dances in the same or related keys: "The musicians were applauded for their outstanding performance of Tchaikovsky's 'Nutcracker Suite.' "
5. In computer science, a group of software products packaged and sold together, usually having a consistent look and feel, a common installation, and shared macros.
6. Etymology: "a train of followers or attendants"; from French suite, from Old French suite, "act of following, attendance".
2. A company that wants to buy another company: "Vaughn and his friends were trying to buy a controlling interest in the drug company."
